Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells |
| |
Authors: | Tsun Yee Tsang Wan Yee Tang Wing Pui Tsang Ngai Na Co Siu Kai Kong Tim Tak Kwok |
| |
Affiliation: | (1) Department of Biochemistry, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;(2) Present address: Department of Environmental Health, University of Cincinnati Medical Center, Cincinnati, OH, USA |
| |
Abstract: | Hepatoma-derived growth factor (HDGF) is highly expressed in human cancer and its expression is correlated with poor prognosis of cancer. The growth factor is known to stimulate cell growth while the underlying mechanism is however not clear. Transfection with HDGF cDNA stimulated while its specific antisense oligonucleotides repressed the growth of human hepatocellular carcinoma HepG2 cells. Furthermore, knock-down of HDGF by antisense oligos also induced apoptosis in HepG2 cells and in other human cancer cells, e.g. human squamous carcinoma A431 cells. HDGF knock-down was found to induce the expression of the pro-apoptotic protein Bad and also inactivate ERK and Akt, which in turn led to dephosphorylation of Bad at Ser-112, Ser-136, and activation of the intrinsic apoptotic pathway, i.e. depolarization of the mitochondrial membrane, release of mitochondrial cytochrome c, increase in the processing of caspase 9 and 3. As HDGF knock-down not only suppresses the growth but also induces apoptosis in human cancer cells, HDGF may therefore serve as a survival factor for human cancer cells and a potential target for cancer therapy. Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users. |
| |
Keywords: | HDGF Apoptosis Bad |
本文献已被 PubMed SpringerLink 等数据库收录! |
|